Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesSQI Diagnostics Inc

SQI Diagnostics Inc

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
None CAD 0.00(0%)
Last update at 2024-04-09T03:57:51.641202Z
Market Cap
6.11M

Momentum Score

…

SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.01
Low
0.12
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
3.04M
Revenue Per Share
0.01
Gross Profit TTM
3.10M
Debt / Equity
-
ROE
-1254.07%
Net Debt
12.30M
ROCE
997.26%
Diluted EPS TTM
-0.05

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Type yearly yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Income before tax -18.52M -10.56M -8.57M -8.02M -7.44M
Net income -18.52M -10.56M -8.57M -8.02M -7.44M
Selling general administrative 6.56M 3.32M 4.11M 7.86M 7.07M
Gross profit 3.10M 0.77M 0.79M 1.28M 0.46M
Reconciled depreciation 3.81M 0.75M 0.80M 0.50M 0.46M
Ebit -13.85M -10.04M -7.89M -7.37M -6.86M
Ebitda -12.12M -9.29M -7.09M -6.87M -6.40M
Operating income -13.85M -10.04M -7.89M -7.37M -6.86M
Interest expense 2.60M 0.52M 0.68M 0.66M 0.58M
Tax provision - - - - -0.21M
Net interest income -2.60M -0.52M -0.68M -0.66M -0.58M
Income tax expense - - - - 0.00M
Total revenue 8.10M 0.92M 1.02M 1.89M 1.33M
Total operating expenses 21.95M 10.96M 8.91M 9.26M 8.19M
Cost of revenue 5.00M 0.15M 0.23M 0.61M 0.88M
Total other income expense net -2.07M - - -0.66M -0.58M
Net income from continuing ops -18.52M -10.56M -8.57M -8.02M -7.44M
Net income applicable to common shares -18.52M -10.56M -8.57M -8.02M -7.44M
Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Type yearly yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Total assets 9.31M 9.06M 8.07M 6.27M 5.83M
Intangible assets 0.38M 0.39M 0.38M 0.48M 0.61M
Other current assets 0.33M 0.24M 0.23M 0.14M -
Total liab 19.13M 7.54M 6.34M 4.74M 3.92M
Total stockholder equity -9.81M 1.53M 1.73M 1.53M 1.92M
Other current liab 0.03M 0.24M 0.20M 0.34M 0.02M
Common stock 89.37M 85.91M 71.87M 64.73M 60.82M
Capital stock 89.37M 85.91M 71.87M 64.73M 60.82M
Retained earnings -132.50M -113.97M -103.42M -94.84M -86.82M
Other assets 0.14M - - - 0.04M
Cash 1.34M 2.29M 2.60M 3.44M 2.40M
Total current liabilities 10.70M 2.95M 1.47M 4.71M 1.07M
Net debt 12.30M - - - 0.38M
Short term debt - - - 3.11M -
Short long term debt 7.34M - - 3.11M -
Other stockholder equity 7.79M 5.60M 10.37M 11.83M 12.86M
Property plant equipment 5.50M 5.02M 4.00M 1.26M 1.40M
Total current assets 3.28M 3.64M 3.67M 4.49M 3.76M
Net tangible assets -10.21M 1.12M 1.32M 1.02M 1.28M
Net receivables 0.37M 0.20M 0.48M 0.20M 0.99M
Long term debt 6.30M 2.20M 2.15M - 2.78M
Inventory 1.24M 0.90M 0.36M 0.71M 0.19M
Accounts payable 3.08M 2.47M 1.04M 1.17M 0.90M
Non currrent assets other 0.14M - - 1.78M 2.08M
Non current assets total 6.04M 5.43M 4.40M 1.78M 2.08M
Capital lease obligations 2.38M 2.62M 2.96M 0.12M 0.22M
Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Type yearly yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Investments -7.50M -1.61M -0.18M -0.20M -0.30M
Change to liabilities 0.40M 1.28M -0.05M 0.60M 0.42M
Total cashflows from investing activities -7.50M -1.61M -0.18M -0.20M -0.30M
Net borrowings 11.29M -0.23M -1.27M -0.16M -0.10M
Total cash from financing activities 16.36M 9.95M 6.29M 6.88M 7.88M
Change to operating activities -0.09M -0.09M -0.09M 0.08M -0.17M
Net income -18.52M -10.56M -8.57M -8.02M -7.44M
Change in cash -0.96M -0.30M -0.85M 1.04M 0.94M
Begin period cash flow 2.29M 2.60M 3.44M 2.40M 1.47M
End period cash flow 1.34M 2.29M 2.60M 3.44M 2.40M
Total cash from operating activities -9.82M -8.64M -6.96M -5.63M -6.65M
Issuance of capital stock 2.79M 10.18M 7.57M 7.04M 7.98M
Depreciation 3.76M 0.72M 0.78M 0.48M 0.45M
Other cashflows from investing activities - - -0.00M -0.00M -0.00M
Change to inventory 0.51M -0.59M -0.00M -0.42M -0.02M
Change to account receivables -0.18M 0.26M -0.43M 0.15M -0.57M
Other cashflows from financing activities 2.25M -0.74M -0.10M -0.09M -0.20M
Change to netincome 4.26M 0.21M 1.30M 1.48M 0.67M
Capital expenditures 1.31M 1.50M 0.15M 0.17M 0.26M
Change in working capital 0.64M 0.95M -0.49M 0.41M -0.34M
Stock based compensation 1.44M 0.18M 0.86M 0.59M -
Other non cash items -0.10M 0.06M 0.16M 0.33M 0.26M
Free cash flow -11.03M -10.28M -7.14M -5.83M -6.95M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AVCR
Avricore Health Inc		 -
-%		 0.05 - - 3.16 5.09 3.30 41.13
TELO
Telo Genomics Corp		 -0.01
10.00%		 0.04 - - - 8.78 - -6.32
ARC
Arian Resources Corp.		 -
-%		 0.01 - - 2.12 - 15.59 2.25
MBI-H
Med BioGene Inc		 -
-%		 0.02 - - - - - -3.03

Profile*

SQI Diagnostics Inc

SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.

36 Meteor Drive, Toronto, ON, Canada, M9W 1A4

416 674 9500

https://www.sqidiagnostics.com

Name Title Year Born
Mr. Andrew Morris CEO & Director 1966
Mr. Morlan Reddock C.F.A., CPA, CGA, M.B.A. CFO & VP of Admin. NA
Dr. Eric Brouwer Ph.D. Chief Scientific Officer & Director 1969
Dr. Peter Lea Ph.D. Founder 1945
Mr. Tim McGough Chief Commercial Officer NA
Mr. Russell Peloquin VP of Global Commercial Operations NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DHT-U
CAD 13.53
+16.44%
LIF
CAD 22.04
+8.62%
TOI
CAD 103.80
+7.09%
CRON
CAD 5.26
+6.69%
CIA
CAD 2.04
+6.25%
ITH
CAD 1.61
-34.02%
IFOS
CAD 1.65
-22.90%
TNZ
CAD 49.70
-19.58%
KEEL
CAD 2.36
-19.45%
GIL
CAD 49.36
-18.33%

Equity Sectors*

  • Basic Materials

    -2.18%

  • Communication Services

    +0.95%

  • Consumer Cyclical

    -2.25%

  • Consumer Defensive

    -0.68%

  • Energy

    -2.93%

  • Financial Services

    -2.26%

  • Healthcare

    -0.46%

  • Industrials

    -3.70%

  • Real Estate

    -0.06%

  • Technology

    -3.32%

  • Utilities

    -0.50%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…